Global Biosimilars Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4864282
- 104 Pages
- February 2022
- Medical Devices
The United States Biosimilars Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilars Treatment market, reaching US$ million by the year 2028. As for the Europe Biosimilars Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biosimilars Treatment players cover Bayer, Eli Lily, Inc., Pfizer, Inc., and Sandoz International GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Recombinant Non – Glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oncology
Chronic and Autoimmune Disease
Blood Disorders
Growth Hormone Disease
Infectious Disease
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
Eli Lily, Inc.
Pfizer, Inc.
Sandoz International GmbH
Teva Pharmaceutical Industries Limited
Amgen Inc.
Biocon
Dr. Reddy’s Laboratories
Roche Ltd.
Celltrion, Inc.
Samsung Bioepis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilars Treatment Market Size 2017-2028
2.1.2 Biosimilars Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biosimilars Treatment Segment by Type
2.2.1 Recombinant Non – Glycosylated Proteins
2.2.2 Recombinant Glycosylated Proteins
2.2.3 Recombinant Peptides
2.3 Biosimilars Treatment Market Size by Type
2.3.1 Biosimilars Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biosimilars Treatment Market Size Market Share by Type (2017-2022)
2.4 Biosimilars Treatment Segment by Application
2.4.1 Oncology
2.4.2 Chronic and Autoimmune Disease
2.4.3 Blood Disorders
2.4.4 Growth Hormone Disease
2.4.5 Infectious Disease
2.5 Biosimilars Treatment Market Size by Application
2.5.1 Biosimilars Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biosimilars Treatment Market Size Market Share by Application (2017-2022)
3 Biosimilars Treatment Market Size by Player
3.1 Biosimilars Treatment Market Size Market Share by Players
3.1.1 Global Biosimilars Treatment Revenue by Players (2020-2022)
3.1.2 Global Biosimilars Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Biosimilars Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilars Treatment by Regions
4.1 Biosimilars Treatment Market Size by Regions (2017-2022)
4.2 Americas Biosimilars Treatment Market Size Growth (2017-2022)
4.3 APAC Biosimilars Treatment Market Size Growth (2017-2022)
4.4 Europe Biosimilars Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Biosimilars Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biosimilars Treatment Market Size by Country (2017-2022)
5.2 Americas Biosimilars Treatment Market Size by Type (2017-2022)
5.3 Americas Biosimilars Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars Treatment Market Size by Region (2017-2022)
6.2 APAC Biosimilars Treatment Market Size by Type (2017-2022)
6.3 APAC Biosimilars Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilars Treatment by Country (2017-2022)
7.2 Europe Biosimilars Treatment Market Size by Type (2017-2022)
7.3 Europe Biosimilars Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilars Treatment by Region (2017-2022)
8.2 Middle East & Africa Biosimilars Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Biosimilars Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilars Treatment Market Forecast
10.1 Global Biosimilars Treatment Forecast by Regions (2023-2028)
10.1.1 Global Biosimilars Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Biosimilars Treatment Forecast
10.1.3 APAC Biosimilars Treatment Forecast
10.1.4 Europe Biosimilars Treatment Forecast
10.1.5 Middle East & Africa Biosimilars Treatment Forecast
10.2 Americas Biosimilars Treatment Forecast by Country (2023-2028)
10.2.1 United States Biosimilars Treatment Market Forecast
10.2.2 Canada Biosimilars Treatment Market Forecast
10.2.3 Mexico Biosimilars Treatment Market Forecast
10.2.4 Brazil Biosimilars Treatment Market Forecast
10.3 APAC Biosimilars Treatment Forecast by Region (2023-2028)
10.3.1 China Biosimilars Treatment Market Forecast
10.3.2 Japan Biosimilars Treatment Market Forecast
10.3.3 Korea Biosimilars Treatment Market Forecast
10.3.4 Southeast Asia Biosimilars Treatment Market Forecast
10.3.5 India Biosimilars Treatment Market Forecast
10.3.6 Australia Biosimilars Treatment Market Forecast
10.4 Europe Biosimilars Treatment Forecast by Country (2023-2028)
10.4.1 Germany Biosimilars Treatment Market Forecast
10.4.2 France Biosimilars Treatment Market Forecast
10.4.3 UK Biosimilars Treatment Market Forecast
10.4.4 Italy Biosimilars Treatment Market Forecast
10.4.5 Russia Biosimilars Treatment Market Forecast
10.5 Middle East & Africa Biosimilars Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Biosimilars Treatment Market Forecast
10.5.2 South Africa Biosimilars Treatment Market Forecast
10.5.3 Israel Biosimilars Treatment Market Forecast
10.5.4 Turkey Biosimilars Treatment Market Forecast
10.5.5 GCC Countries Biosimilars Treatment Market Forecast
10.6 Global Biosimilars Treatment Forecast by Type (2023-2028)
10.7 Global Biosimilars Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Biosimilars Treatment Product Offered
11.1.3 Bayer Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eli Lily, Inc.
11.2.1 Eli Lily, Inc. Company Information
11.2.2 Eli Lily, Inc. Biosimilars Treatment Product Offered
11.2.3 Eli Lily, Inc. Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eli Lily, Inc. Main Business Overview
11.2.5 Eli Lily, Inc. Latest Developments
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Information
11.3.2 Pfizer, Inc. Biosimilars Treatment Product Offered
11.3.3 Pfizer, Inc. Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer, Inc. Main Business Overview
11.3.5 Pfizer, Inc. Latest Developments
11.4 Sandoz International GmbH
11.4.1 Sandoz International GmbH Company Information
11.4.2 Sandoz International GmbH Biosimilars Treatment Product Offered
11.4.3 Sandoz International GmbH Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sandoz International GmbH Main Business Overview
11.4.5 Sandoz International GmbH Latest Developments
11.5 Teva Pharmaceutical Industries Limited
11.5.1 Teva Pharmaceutical Industries Limited Company Information
11.5.2 Teva Pharmaceutical Industries Limited Biosimilars Treatment Product Offered
11.5.3 Teva Pharmaceutical Industries Limited Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Teva Pharmaceutical Industries Limited Main Business Overview
11.5.5 Teva Pharmaceutical Industries Limited Latest Developments
11.6 Amgen Inc.
11.6.1 Amgen Inc. Company Information
11.6.2 Amgen Inc. Biosimilars Treatment Product Offered
11.6.3 Amgen Inc. Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Inc. Main Business Overview
11.6.5 Amgen Inc. Latest Developments
11.7 Biocon
11.7.1 Biocon Company Information
11.7.2 Biocon Biosimilars Treatment Product Offered
11.7.3 Biocon Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Biocon Main Business Overview
11.7.5 Biocon Latest Developments
11.8 Dr. Reddy’s Laboratories
11.8.1 Dr. Reddy’s Laboratories Company Information
11.8.2 Dr. Reddy’s Laboratories Biosimilars Treatment Product Offered
11.8.3 Dr. Reddy’s Laboratories Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Dr. Reddy’s Laboratories Main Business Overview
11.8.5 Dr. Reddy’s Laboratories Latest Developments
11.9 Roche Ltd.
11.9.1 Roche Ltd. Company Information
11.9.2 Roche Ltd. Biosimilars Treatment Product Offered
11.9.3 Roche Ltd. Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Roche Ltd. Main Business Overview
11.9.5 Roche Ltd. Latest Developments
11.10 Celltrion, Inc.
11.10.1 Celltrion, Inc. Company Information
11.10.2 Celltrion, Inc. Biosimilars Treatment Product Offered
11.10.3 Celltrion, Inc. Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Celltrion, Inc. Main Business Overview
11.10.5 Celltrion, Inc. Latest Developments
11.11 Samsung Bioepis
11.11.1 Samsung Bioepis Company Information
11.11.2 Samsung Bioepis Biosimilars Treatment Product Offered
11.11.3 Samsung Bioepis Biosimilars Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Samsung Bioepis Main Business Overview
11.11.5 Samsung Bioepis Latest Developments
12 Research Findings and Conclusion
Table 1. Biosimilars Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Recombinant Non – Glycosylated Proteins
Table 3. Major Players of Recombinant Glycosylated Proteins
Table 4. Major Players of Recombinant Peptides
Table 5. Biosimilars Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Biosimilars Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Biosimilars Treatment Market Size Market Share by Type (2017-2022)
Table 8. Biosimilars Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Biosimilars Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Biosimilars Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Biosimilars Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Biosimilars Treatment Revenue Market Share by Player (2020-2022)
Table 13. Biosimilars Treatment Key Players Head office and Products Offered
Table 14. Biosimilars Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biosimilars Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Biosimilars Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Biosimilars Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Biosimilars Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Biosimilars Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Biosimilars Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Biosimilars Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Biosimilars Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Biosimilars Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Biosimilars Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Biosimilars Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Biosimilars Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Biosimilars Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Biosimilars Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Biosimilars Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Biosimilars Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Biosimilars Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Biosimilars Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Biosimilars Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Biosimilars Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Biosimilars Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Biosimilars Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Biosimilars Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Biosimilars Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Biosimilars Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Biosimilars Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Biosimilars Treatment
Table 44. Key Market Challenges & Risks of Biosimilars Treatment
Table 45. Key Industry Trends of Biosimilars Treatment
Table 46. Global Biosimilars Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Biosimilars Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Biosimilars Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Biosimilars Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Biosimilars Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Biosimilars Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Bayer Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 53. Bayer Biosimilars Treatment Product Offered
Table 54. Bayer Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Bayer Main Business
Table 56. Bayer Latest Developments
Table 57. Eli Lily, Inc. Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 58. Eli Lily, Inc. Biosimilars Treatment Product Offered
Table 59. Eli Lily, Inc. Main Business
Table 60. Eli Lily, Inc. Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Eli Lily, Inc. Latest Developments
Table 62. Pfizer, Inc. Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 63. Pfizer, Inc. Biosimilars Treatment Product Offered
Table 64. Pfizer, Inc. Main Business
Table 65. Pfizer, Inc. Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer, Inc. Latest Developments
Table 67. Sandoz International GmbH Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 68. Sandoz International GmbH Biosimilars Treatment Product Offered
Table 69. Sandoz International GmbH Main Business
Table 70. Sandoz International GmbH Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Sandoz International GmbH Latest Developments
Table 72. Teva Pharmaceutical Industries Limited Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 73. Teva Pharmaceutical Industries Limited Biosimilars Treatment Product Offered
Table 74. Teva Pharmaceutical Industries Limited Main Business
Table 75. Teva Pharmaceutical Industries Limited Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Teva Pharmaceutical Industries Limited Latest Developments
Table 77. Amgen Inc. Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 78. Amgen Inc. Biosimilars Treatment Product Offered
Table 79. Amgen Inc. Main Business
Table 80. Amgen Inc. Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Amgen Inc. Latest Developments
Table 82. Biocon Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 83. Biocon Biosimilars Treatment Product Offered
Table 84. Biocon Main Business
Table 85. Biocon Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Biocon Latest Developments
Table 87. Dr. Reddy’s Laboratories Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 88. Dr. Reddy’s Laboratories Biosimilars Treatment Product Offered
Table 89. Dr. Reddy’s Laboratories Main Business
Table 90. Dr. Reddy’s Laboratories Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Dr. Reddy’s Laboratories Latest Developments
Table 92. Roche Ltd. Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 93. Roche Ltd. Biosimilars Treatment Product Offered
Table 94. Roche Ltd. Main Business
Table 95. Roche Ltd. Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Roche Ltd. Latest Developments
Table 97. Celltrion, Inc. Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 98. Celltrion, Inc. Biosimilars Treatment Product Offered
Table 99. Celltrion, Inc. Main Business
Table 100. Celltrion, Inc. Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Celltrion, Inc. Latest Developments
Table 102. Samsung Bioepis Details, Company Type, Biosimilars Treatment Area Served and Its Competitors
Table 103. Samsung Bioepis Biosimilars Treatment Product Offered
Table 104. Samsung Bioepis Biosimilars Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Samsung Bioepis Main Business
Table 106. Samsung Bioepis Latest Developments
List of Figures
Figure 1. Biosimilars Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biosimilars Treatment Market Size Market Share by Type in 2021
Figure 7. Biosimilars Treatment in Oncology
Figure 8. Global Biosimilars Treatment Market: Oncology (2017-2022) & ($ Millions)
Figure 9. Biosimilars Treatment in Chronic and Autoimmune Disease
Figure 10. Global Biosimilars Treatment Market: Chronic and Autoimmune Disease (2017-2022) & ($ Millions)
Figure 11. Biosimilars Treatment in Blood Disorders
Figure 12. Global Biosimilars Treatment Market: Blood Disorders (2017-2022) & ($ Millions)
Figure 13. Biosimilars Treatment in Growth Hormone Disease
Figure 14. Global Biosimilars Treatment Market: Growth Hormone Disease (2017-2022) & ($ Millions)
Figure 15. Biosimilars Treatment in Infectious Disease
Figure 16. Global Biosimilars Treatment Market: Infectious Disease (2017-2022) & ($ Millions)
Figure 17. Global Biosimilars Treatment Market Size Market Share by Application in 2021
Figure 18. Global Biosimilars Treatment Revenue Market Share by Player in 2021
Figure 19. Global Biosimilars Treatment Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Biosimilars Treatment Market Size 2017-2022 ($ Millions)
Figure 21. APAC Biosimilars Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Europe Biosimilars Treatment Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Biosimilars Treatment Market Size 2017-2022 ($ Millions)
Figure 24. Americas Biosimilars Treatment Value Market Share by Country in 2021
Figure 25. Americas Biosimilars Treatment Consumption Market Share by Type in 2021
Figure 26. Americas Biosimilars Treatment Market Size Market Share by Application in 2021
Figure 27. United States Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Biosimilars Treatment Market Size Market Share by Region in 2021
Figure 32. APAC Biosimilars Treatment Market Size Market Share by Application in 2021
Figure 33. China Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Biosimilars Treatment Market Size Market Share by Country in 2021
Figure 40. Europe Biosimilars Treatment Market Size Market Share by Type in 2021
Figure 41. Europe Biosimilars Treatment Market Size Market Share by Application in 2021
Figure 42. Germany Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Biosimilars Treatment Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Biosimilars Treatment Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Biosimilars Treatment Market Size Market Share by Application in 2021
Figure 50. Egypt Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Biosimilars Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 56. APAC Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Europe Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 59. United States Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Canada Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 63. China Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Japan Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Korea Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 67. India Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Australia Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Germany Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 70. France Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 71. UK Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Italy Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Russia Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Spain Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 77. Israel Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Biosimilars Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
